2019 American Transplant Congress
Azole Use and Fungal Pathogens in Cystic Fibrosis versus Non-Cystic Fibrosis Lung Transplant Recipients
*Purpose: Cystic fibrosis (CF) patients exhibit unique pharmacokinetic principles. Azole antifungals show marked inter- and intra-patient variability. We aimed to improve itraconazole (ITR) use and…2019 American Transplant Congress
Anti-Fungal Prophylaxis in Lung Transplant: A Systematic Review/Meta-Analysis
*Purpose: Invasive fungal infections (IFI) increase morbidity and mortality after lung transplant. Despite this, anti-fungal prophylaxis (AFP) in lung transplant recipients (LTR) varies by prophylactic…2019 American Transplant Congress
Facial Composite Tissue Allotransplantation: First Canadian Experience
1Hopital Maisonneuve-Rosemont, Montreal, QC, Canada, 2University of Montreal, Montreal, QC, Canada
*Purpose: Facial vascularized composite allotransplantation (VCA) has emerged as a groundbreaking reconstructive solution for patients with severely disfiguring facial injuries. It allows simultaneous “like with…2019 American Transplant Congress
Transmission of Infections from Organ Donor to Recipient – German Data
German Foundation for Organtransplantation (DSO), Frankfurt, Germany
*Purpose: In Europe, vigilance monitoring after organ transplant includes Serious Adverse Events (SAE) as well as Serious Adverse Reactions (SAR). All SAE and SAR related…2019 American Transplant Congress
Breakthrough Invasive Fungal Infections in Solid Organ Transplant Patients Receiving Isavuconazole
University of California, San Francisco, San Francisco, CA
*Purpose: Isavuconazole (ISA) is a broad-spectrum triazole antifungal approved in 2015 for the treatment of invasive aspergillosis and mucormycosis. While it is increasingly used in…2019 American Transplant Congress
Targeted Antifungal Prophylaxis in Liver Transplant Recipients: Two Year, Retrospective Cohort Analysis
*Purpose: No consensus exists regarding systemic antifungal prophylaxis in liver transplant recipients (LTRs) in terms of optimal duration, choice of agent, or risk factors to…2018 American Transplant Congress
Cryptococcal Infections in Kidney Transplant Recipients. A Single Center Experience
Cryptococcal infections are infrequent but a cause of morbidity & mortality in transplant (T) recipients. Best treatment and the need for secondary prophylaxis are still…2018 American Transplant Congress
Transplant Tourism and Invasive Fungal Infection
Deceased and live-related Renal transplant (RTX) are widespread approved methods throughout the world. In-addition, commercial-RTX has gained an access at certain places driven by financial…2018 American Transplant Congress
Retrospective Study of Cryptococcosis in Kidney Transplant Recipients from a Single Center
Background: The mortality of Cryptococcosis remains unchanged among kidney transplant recipients(KTR) over the past two decades, and the prognosis of Cryptococcosis is yet unpredicted. Hence,…2018 American Transplant Congress
Rates of Posttransplant Cutaneous Disease Differ between Black and White Solid Organ Transplant Recipients
Background: Immunosuppression (IS) results in heightened risk of developing posttransplant cutaneous complications. Black solid organ transplant recipients (OTRs), who often receive higher doses of IS…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 10
- Next Page »